Refresco and a consortium of PAI and bcIMC agree on a

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
39
Refresco and a consortium of PAI and bcIMC agree on a recommended cash public offer of EUR 20 per share for all shares of Refresco

This is a joint press release by Refresco Group N.V. ("Refresco" or the "Company"), PAI Partners SAS ("PAI") and British Columbia Investment Management Corporation ("bcIMC") acting jointly through Sunshine Investments B.V. (the "Offeror" or the "Consortium"),  pursuant to the provisions of Section 4, paragraphs 1 and 3, Section 5, paragraph 1 and Section 7, paragraph 4 of the Netherlands Decree in Public Takeover Bids (Besluit openbare biedingen Wft, (the "Decree") in connection with the intended public offer by the Offeror for all the issued and outstanding ordinary shares in the capital of Refresco (the "Shares"). This announcement does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities in Refresco. Any offer will be made only by means of an offer memorandum (the "Offer Memorandum") approved by the AFM. This announcement is not for release, publication or distribution, in whole or in part, in or into, directly or indirectly, the United States.

Paris, France / Victoria, British Columbia, Canada / Rotterdam, the Netherlands - 25 October 2017

  • A Consortium of PAI Partners SAS ("PAI") and British Columbia Investment Management Corporation ("bcIMC") to make a recommended offer of EUR 20 (cum dividend) in cash per ordinary share of Refresco (the "Offer Price") for a consideration of EUR 1.623 billion
  • The Offer Price represents:
  • a premium of approximately 22% to the average Refresco closing share price of EUR 16.37 since the announcement of the acquisition of Cott's bottling activities ("Cott TB") on 25 July 2017 (the "Average Share Price") [1] ;
  • a premium of approximately 41% to the Refresco closing share price of EUR 14.21 on 5 April 2017 (the "April Share Price") [2] ; and
  • an Enterprise Value to EBITDA multiple of approximately 8.5x post Cott TB synergies for the twelve-month period ending 30 June 2017 [3]
  • The Consortium fully supports Refresco's buy-and-build strategy going forward, including the completion of the Cott TB acquisition
  • Major shareholders and shareholding members of the Boards, holding in aggregate 26.5% of the total issued and outstanding shares, have committed to tender all their shares
  • The Consortium has committed financing in place, providing high deal certainty
  • Refresco's Executive Board and Supervisory Board fully support and unanimously recommend the offer

With reference to the press releases of Refresco Group N.V. on 3 October 2017 and 17 October 2017, PAI, bcIMC and Refresco today jointly announce that they have reached conditional agreement on a recommended, fully funded, public offer by a consortium of PAI and bcIMC, acting jointly through Sunshine Investments B.V. ("the Offeror" or the "Consortium") for all the issued and outstanding ordinary shares of Refresco (the "Shares") at an offer price of EUR 20 (cum dividend) in cash per Share (the "Offer").

The Offer Price represents a premium of approximately 22% to the Average Share Price, a premium of approximately 41% to the April Share Price, and a premium of approximately 38% to the Refresco IPO price. The Offer Price values 100% of the Shares at EUR 1.623 billion and equates to an Enterprise Value of approximately EUR 3.3 billion, which implies an EBITDA multiple of 8.5x post Cott TB synergies for the twelve-month period ending 30 June 2017.

The Offer provides Refresco's shareholders with a fair price for their Shares including an attractive premium. The Consortium has fully committed financing in place on a "certain funds" basis and has completed its due diligence, providing high deal certainty and facilitating a swift and efficient transaction process to completion.

Hans Roelofs, CEO of Refresco: "This Offer represents a fair value for our shareholders and is yet another milestone for the Company. The Consortium fully supports our strategy and with its track record, financial strength and understanding of our business, they can support the Company whilst we accelerate our growth plan going forward.

Obtaining a public listing in 2015 was a well-considered decision and it has brought the Company many opportunities. However, we have also grown and prospered under private equity ownership. Our ownership structure is never a goal in itself. Rather, our focus remains on being in an environment that allows us to continue executing our proven strategy of buy-and-build.

The first time PAI approached us was prior to our public listing in 2015. They have always been impressed by our business and performance, and the agreement reached today reflects the important steps Refresco has realised since the IPO. Our latest acquisition of Cott TB, creating the world's largest independent bottler with leadership positions across Europe and North America, is a truly transformational acquisition right at the heart of our buy-and-build strategy.

We are convinced that this is a good transaction for the Company and all stakeholders involved and we therefore recommend our shareholders to accept the Offer. Our focus of growing alongside our customers in the markets where we currently operate and expanding geographically remains unchanged. I look forward to this new phase of private ownership, and for all our employees and customers to capitalize on the opportunities ahead of us."

Frédéric Stévenin, Managing Partner, PAI: "Refresco is a high-quality business and an attractive consolidation platform in the beverage industry which we intend to fully support using PAI's wealth of experience in the European food and beverage industry. We share the Refresco management team's overall vision for the group and we are excited by the opportunity to work with them and the team at bcIMC to realise its potential."

Jim Pittman, Senior Vice President, Private Equity at bcIMC: "bcIMC has followed Refresco with interest for several years. We feel its scale, global presence, and track record of growth are a good fit for our clients' portfolios. We are keen to work with PAI, a long-term strategic partner, to support Refresco and management in the execution of its strategic plans over the coming years." 

Please open the link below for the press release.

[1] Average share price for period from 25 July 2017 up to and including 2 October 2017, the date prior to Refresco's public announcement of PAI and bcIMC's renewed interest in a take private transaction.

[2] Share price prior to PAI's proposal of 6 April 2017 and subsequent public announcement made by Refresco, adjusted for the FY2016 dividend of EUR 0.38 per share paid on 6 June 2017.

[3] Pro forma for the Cott TB acquisition including full run-rate synergies of EUR 47 million.

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...dc119963b8

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 5

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 3

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading

Top 5 Most Recently Viewed Articles

Bitcoin's Path to $100,000: Expert Insights and Predictions

Updated Category News Views 115

Bitcoin's Potential Surge Towards $100,000 Crypto analyst Trader Mayne has recently suggested that Bitcoin could be preparing for one final push toward the impressive milestone of $100,000. He notes, however, that the overall market cycle resembles a prolonged five-year super cycle, which may culminate in a significant downturn in the near future. Current Market...

Continue Reading
Executive Leadership Shift at Geisinger with Dr. Mitchell

Updated Category News Views 755

Geisinger Appoints Jason W. Mitchell, M.D. as CMO In a notable leadership transition, Geisinger has officially announced the appointment of Jason W. Mitchell, M.D. as its executive vice president and chief medical officer. This decision comes after an exhaustive search aimed at finding a leader with the vision and expertise to guide the organization into its next chapter....

Continue Reading
What Investors Should Expect from Euroseas Earnings Release

Updated Category News Views 131

Insights Ahead of Euroseas's Earnings Report Euroseas (NASDAQ:ESEA) is gearing up to unveil its latest quarterly earnings, a moment that investors eagerly anticipate. This report holds substantial importance, as it can influence both investor sentiment and stock performance significantly. What Analysts Are Predicting Leading up to the earnings announcement, analysts...

Continue Reading
Establishing Strategic Ties: AEGGIS Summit Focus on Growth

Updated Category News Views 237

Atlantic Council and Antenna Group Unite for AEGGIS The Atlantic Council and Antenna Group have unveiled an exciting initiative known as the Alliance for Europe–Gulf Geopolitics & Investments Summit (AEGGIS). This summit is poised to play a pivotal role in strengthening the economic connections between European and Gulf nations. A Platform for Engagement and Dialogue...

Continue Reading
China Pharma Closes $5M Offering: What Lies Ahead?

Updated Category News Views 14

China Pharma's $5 Million Secured: A Strategic Move? Tough out there in the pharma jungle, isn't it? China Pharma Holdings, Inc. (NYSE American: CPHI) just wrapped up a neat $5 million direct offering. With each of their 2.5 million shares going for two bucks a pop, they're setting sails in a tumultuous sea. Now, why does this matter? Well, cash moshes in the pharma pit...

Continue Reading